Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Applied Therapeutics IncCOMM | 6,567,858 | 6,567,858 | 0 | $30.67M | $55.83M | 32.38% | +$25.15M |
| Plains GP Holdings, L.P.COMM(PAGP) | 1,372,360 | 1,272,360 | -100,000 | $25.83M | $23.54M | 13.65% | -$2.29M |
| Phathom Pharmaceuticals, Inc.COMM(PHAT) | 869,927 | 869,927 | 0 | $8.96M | $15.73M | 9.12% | +$6.77M |
| Achieve Life Sciences IncCOMM | 2,453,092 | 2,453,092 | 0 | $11.53M | $11.63M | 6.74% | +$98.1K |
| TScan Therapeutics, Inc.COMM(TCRX) | 2,087,139 | 2,087,139 | 0 | $12.21M | $10.39M | 6.03% | -$1.82M |
| Akero Therapeutics IncCOMM | 327,752 | 343,729 | +15,977 | $7.69M | $9.86M | 5.72% | +$2.17M |
| Madrigal Pharmaceuticals, Inc.COMM(MDGL) | 43,032 | 43,032 | 0 | $12.06M | $9.13M | 5.30% | -$2.92M |
| Avidity Biosciences IncCOMM | 178,500 | 178,500 | 0 | $7.29M | $8.20M | 4.76% | +$906.8K |
| Ardelyx IncCOMM | 924,583 | 1,070,947 | +146,364 | $6.85M | $7.38M | 4.28% | +$527.7K |
| Telesat CorporationCOMM(TSAT) | 365,781 | 365,781 | 0 | $3.33M | $4.82M | 2.79% | +$1.49M |
| Abeona Therapeutics Inc.COMM(ABEO) | 1,248,044 | 624,022 | -624,022 | $5.29M | $3.94M | 2.29% | -$1.35M |
| Kymera Therapeutics, Inc.COMM(KYMR) | 56,359 | 56,359 | 0 | $1.68M | $2.67M | 1.55% | +$985.2K |
| Syndax Pharmaceuticals, Inc.COMM(SNDX) | 83,259 | 133,259 | +50,000 | $1.71M | $2.57M | 1.49% | +$855.9K |
| Kura Oncology, Inc.COMM(KURA) | 130,000 | 130,000 | 0 | $2.68M | $2.54M | 1.47% | -$136.5K |
| Zevra Therapeutics, Inc.COMM(ZVRA) | 0 | 179,874 | +179,874 | $0 | $1.25M | 0.72% | +$1.25M |
| Eiger BiopharmaceuticalsCOMM | 146,381 | 146,381 | 0 | $1.85M | $1.24M | 0.72% | -$607.5K |
| Athira Pharma IncCOMM | 1,492,792 | 1,492,792 | 0 | $3.96M | $665.8K | 0.39% | -$3.29M |
| COMPASS Pathways plcCOMM(CMPS) | 0 | 80,000 | +80,000 | $0 | $504.0K | 0.29% | +$504.0K |
| Verrica Pharmaceuticals Inc.COMM(VRCA) | 424,937 | 344,937 | -80,000 | $3.10M | $500.2K | 0.29% | -$2.60M |
| Maat Pharma SacaCOMM | 0 | 2,397 | +2,397 | $0 | $17.8K | 0.01% | +$17.8K |
| Chinook TherapeuticsCOMM | 79,357 | 79,357 | 0 | $9.8K | $9.8K | 0.01% | $0 |
| Cybin D/B/A Helus PharmaCOMM(HELP) | 850,000 | 0 | -850,000 | $230.3K | $0 | — | -$230.3K |
| Fulcrum Therapeutics, Inc.COMM(FULC) | 750,000 | 0 | -750,000 | $4.65M | $0 | — | -$4.65M |
| Trevi Therapeutics, Inc.COMM(TRVI) | 260,000 | 0 | -260,000 | $774.8K | $0 | — | -$774.8K |
| Maat Pharma SacaCOMM | 1,362 | 0 | -1,362 | $9.8K | $0 | — | -$9.8K |
| Kayne Anderson Energy Infrastructure Fund, Inc.COMM(KYN) | 147,033 | 0 | -147,033 | $1.52M | $0 | — | -$1.52M |
| Fidelity Inv Mmtrsy 1 680COMM | 317,014 | 0 | -317,014 | $317.0K | $0 | — | -$317.0K |